Viewing Study NCT04088734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-03-06 @ 11:46 PM
Study NCT ID: NCT04088734
Status: TERMINATED
Last Update Posted: 2023-07-25
First Post: 2019-09-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease
Sponsor: Ultragenyx Pharmaceutical Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MPS IIIA View
None Sanfilippo Syndrome View
None Sanfilippo A View
None Mucopolysaccharidosis III View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MPS IIIA View
None Sanfilippo View
None Gene therapy View